218 related articles for article (PubMed ID: 12796798)
1. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.
Ebihara Y; Manabe A; Tanaka R; Yoshimasu T; Ishikawa K; Iseki T; Hayakawa J; Maeda M; Asano S; Tsuji K
Bone Marrow Transplant; 2003 Jun; 31(12):1169-71. PubMed ID: 12796798
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
3. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
6. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation.
Takami A; Nakao S; Yachie A; Kasahara Y; Okumura H; Miura Y; Sugimori N; Zeng W; Wang H; Kotani T; Shiobara S; Matsuda T
Bone Marrow Transplant; 1998 Jun; 21(12):1279-82. PubMed ID: 9674865
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection.
Ogata M; Imamura T; Mizunoe S; Ohtsuka E; Kikuchi H; Nasu M
Am J Hematol; 2003 Jun; 73(2):126-30. PubMed ID: 12749015
[TBL] [Abstract][Full Text] [Related]
9. Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy.
Matsunaga T; Kurosawa H; Okuya M; Nakajima D; Hagisawa S; Sato Y; Fukushima K; Sugita K; Arisaka O
Pediatr Transplant; 2009 Mar; 13(2):231-4. PubMed ID: 18627511
[TBL] [Abstract][Full Text] [Related]
10. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
Taketani T; Kikuchi A; Inatomi J; Hanada R; Kawaguchi H; Ida K; Oh-Ishi T; Arai T; Kishimoto H; Yamamoto K
Bone Marrow Transplant; 2002 Mar; 29(6):531-3. PubMed ID: 11960276
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
12. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S
Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
[TBL] [Abstract][Full Text] [Related]
13. [Epstein-Barr virus associated natural killer cell leukemia: report of an autopsy case].
Takai K; Sanada M; Shibuya H
Rinsho Ketsueki; 1995 May; 36(5):500-5. PubMed ID: 7783357
[TBL] [Abstract][Full Text] [Related]
14. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal expansion of Epstein-Barr virus-infected natural killer cells after allogeneic peripheral blood stem cell transplantation.
Isobe Y; Hamano Y; Ito Y; Kimura H; Tsukada N; Sugimoto K; Komatsu N
J Clin Virol; 2013 Feb; 56(2):150-2. PubMed ID: 23194777
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
17. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.
Ishimura M; Ohga S; Nomura A; Toubo T; Morihana E; Saito Y; Nishio H; Ide M; Takada H; Hara T
Am J Hematol; 2005 Nov; 80(3):207-12. PubMed ID: 16247742
[TBL] [Abstract][Full Text] [Related]
18. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
[TBL] [Abstract][Full Text] [Related]
19. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
